Login / Signup

Review of Calcipotriene and Betamethasone Dipropionate Cream in the Treatment of Psoriasis.

Alexandra TaylorRohan SinghSteven Richard Feldman
Published in: The Annals of pharmacotherapy (2022)
Newly FDA-approved C-BD cream with novel polyaphron dispersion (PAD) technology provides a safe efficacious combination therapy for mild-to-moderate psoriasis which may be preferred by some patients.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • chronic kidney disease
  • combination therapy
  • atopic dermatitis